Craig R. Rayner's most recent trade in Certara Inc was a trade of 48,462 Common Stock done at an average price of $36.6 . Disclosure was reported to the exchange on Sept. 2, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Certara Inc | Craig R. Rayner | PRESIDENT, INTEGRATED DRUG DEV | Sale of securities on an exchange or to another person at price $ 36.64 per share. | 02 Sep 2021 | 48,462 | 316,210 | - | 36.6 | 1,775,648 | Common Stock |
Certara Inc | Craig R. Rayner | PRESIDENT, INTEGRATED DRUG DEV | Sale of securities on an exchange or to another person at price $ 33.51 per share. | 02 Sep 2021 | 3,900 | 366,572 | - | 33.5 | 130,689 | Common Stock |
Certara Inc | Craig R. Rayner | PRESIDENT, INTEGRATED DRUG DEV | Sale of securities on an exchange or to another person at price $ 34.15 per share. | 02 Sep 2021 | 1,900 | 364,672 | - | 34.2 | 64,885 | Common Stock |
Certara Inc | Craig R. Rayner | PRESIDENT, INTEGRATED DRUG DEV | Sale of securities on an exchange or to another person at price $ 37.21 per share. | 02 Sep 2021 | 200 | 316,010 | - | 37.2 | 7,442 | Common Stock |
Certara Inc | Craig R. Rayner | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 23,810 | 464,744 | - | 0 | Common Stock |